Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades

Clinical Infectious Diseases

Volumn 52, Issue 6, 2011, Pages 726-735

  Valdez, Jessica M ^a,b   Scheinberg, Phillip ^c   Nunez, Olga ^c   Wu, Colin O ^d   Young, Neal S ^c   Walsh, Thomas J ^b,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Hematology Branch   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; ANTIFUNGAL AGENT; CEFTAZIDIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEOXYCHOLATE AMPHOTERICIN B; IMIPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; THYMOCYTE ANTIBODY; TOBRAMYCIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APLASTIC ANEMIA; ARTICLE; ASPERGILLUS; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CAUSE OF DEATH; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE REGIMEN; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; FUNGAL SINUSITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NEUTROPHIL COUNT; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY; RISK FACTOR; SEVERE APLASTIC ANEMIA; STAPHYLOCOCCUS INFECTION; SYSTEMIC MYCOSIS; TREATMENT RESPONSE;

ADULT; ANEMIA, APLASTIC; COMMUNICABLE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 79953760547     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciq245     Document Type: Article

References (26)

1. Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988; 70:177-182.
2. Storb R, Thomas ED, Weiden PL, et al. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 1976; 48:817-841.
3. Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991; 324:1297-1304.
4. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85:3058-3065.
5. Weinberger M, Elattar I, Marshall D, et al. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992; 71:24-43.
6. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 2000; 95:1931-1934. (Pubitemid 30151628)
7. Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000; 96:2049-2054.
8. Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108:2509-2519.
9. Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003; 289:1130-1135. (Pubitemid 37430327)
10. Doney K, Storb R, Buckner CD, et al. Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 1987; 15:239-242. (Pubitemid 17066433)
11. Scheinberg P, Wu CO, Nunez O, Boss C, Sloand EM, Young NS. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica 2009; 94:348-354.
12. Scheinberg P, Nunez O, Wu C, Young NS. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 2006; 133:606-611. (Pubitemid 43742774)
13. Tisdale JF, Dunn DE, Geller N, et al. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 2000; 356:1554-1559.
14. Brodsky RA, Sensenbrenner LL, Smith BD, et al. Durable treatmentfree remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 2001; 135:477-483. (Pubitemid 32923564)
15. Scheinberg P, Nunez O, Young NS. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. Br J Haematol 2006; 133:622-627. (Pubitemid 43742776)
16. Willis F, Marsh JC, Bevan DH, et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 2001; 114:891-898. (Pubitemid 32953751)
17. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-340.
18. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72:101-111. (Pubitemid 12090793)
19. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International antimicrobial therapy Cooperative group. Am J Med 1989; 86:668-672.
20. Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and infectious diseases mycoses study group. N Engl J Med 1999; 340:764-771. (Pubitemid 29114295)
21. Walsh TJ, Pappas P, Winston DJ, et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002; 346: 225-234. (Pubitemid 34438861)
22. Cordonnier C, Pautas C, Maury S, et al. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial. Clin Infect Dis 2009; 48:1042-1051.
23. Tichelli A, Socie G, Henry-Amar M, et al. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European group for blood and marrow transplantation severe aplastic anaemia working party. Ann Intern Med 1999; 130:193-201.
24. Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 2009; 144:206-216.
25. Shlaes DM, Binczewski B, Rice LB. Emerging antimicrobial resistance and the immunocompromised host. Clin Infect Dis 1993; 17(Suppl. 2):S527-S536. (Pubitemid 23322852)
26. Pournaras S, Iosifidis E, Roilides E. Advances in antibacterial therapy against emerging bacterial pathogens. Semin Hematol 2009; 46:198-211.